Roberto Tessari
Negrar, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparison.
Journal: Frontiers in oncology
Published: May 17, 2026
Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparison.
Journal: Frontiers in oncology
Published: February 02, 2026
A New Model for Bone Health Management in Postmenopausal Early Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy-The Predict & Prevent Project.
Journal: Healthcare (Basel, Switzerland)
Published: September 15, 2025
Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh.
Journal: Hospital pharmacy
Published: November 19, 2024
Cost Saving Analysis of an Enhanced Recovery After Surgery (ERAS) Program for Elective Colorectal Surgery in an ERAS Qualified and Training Center.
Journal: World journal of surgery
Published: September 23, 2024
Case Report: Nephrocalcinosis in an infant due to vitamin-D food supplement overdose.
Journal: Frontiers in pediatrics
Published: August 24, 2024
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the "ilmiovaccinoCOVID19 collaborating group".
Journal: Frontiers in drug safety and regulation
Published: December 29, 2023
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts.
Journal: European journal of hospital pharmacy : science and practice
Published: February 27, 2023
Validation of orthopedic allograft preparation process: a new application of media fill test.
Journal: Cell and tissue banking
Published: January 30, 2023
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.
Journal: International journal of antimicrobial agents
Published: November 09, 2021
Last Updated: 09/26/2026